Sign In
Buy STIM
$1.20
-0.0300 (-2.44%)
At Close: Jun 22, 2026
Neuronetics to Report Fourth Quarter 2022 Financial and Operating Results and Host Conference Call
04:35pm, Wednesday, 22'nd Feb 2023
MALVERN, Pa., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve th
Why I Am Passing On BrainsWay And Neuronetics
11:46am, Friday, 17'th Feb 2023
I am bullish on the niche industry that uses magnetic stimulation for brain therapies. BrainsWay and Neuronetics are US-listed stocks in this niche, however they are highly unprofitable with volatile
Neuronetics: An Overdue Checkup
02:29pm, Monday, 13'th Feb 2023
Today, we revisit a small medical device company called Neuronetics for the first time since January 2021. The stock is up some 30% over that time as Neuronetics has seen some notable milestones and d
Neuronetics and Greenbrook TMS Announce Six Year Exclusive Partnership
01:30pm, Thursday, 19'th Jan 2023 GlobeNewswire Inc.
MALVERN, Pa. and TORONTO, Jan. 19, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products t
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09:29pm, Wednesday, 18'th Jan 2023 GlobeNewswire Inc.
MALVERN, Pa., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve
Neuronetics Announces Data Confirming Efficacy in Treating Anxious Depression with NeuroStar® Advanced Therapy for Mental Health
01:32pm, Tuesday, 17'th Jan 2023 GlobeNewswire Inc.
Peer-reviewed publication shows NeuroStar TMS as an effective non-drug treatment for depression with comorbid anxiety Peer-reviewed publication shows NeuroStar TMS as an effective non-drug treatment f
Neuronetics Settles Litigation Against BrainsWay
01:00pm, Tuesday, 10'th Jan 2023 GlobeNewswire Inc.
MALVERN, Pa., Jan. 10, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve
Neuronetics Reports Preliminary Fourth Quarter and Fiscal Year 2022 Financial Results
01:30pm, Monday, 09'th Jan 2023 GlobeNewswire Inc.
MALVERN, Pa., Jan. 09, 2023 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical technology company focused on designing, developing, and marketing products that improve
Neuronetics Announces Appointment of Joseph H. Capper to its Board of Directors
09:29pm, Thursday, 29'th Dec 2022 GlobeNewswire Inc.
New Director Brings Extensive Experience to Poise the Company for Growth New Director Brings Extensive Experience to Poise the Company for Growth
5 Winning Medical Product Stocks That Still Have Room to Run
02:04pm, Tuesday, 27'th Dec 2022 Zacks Investment Research
Despite ongoing macro challenges, medical product stocks like Cardinal Health (CAH), TransMedics Group (TMDX), Olink Holding (OLK), Silk Road Medical (SILK) and Neuronetics (STIM) are likely to gain f
Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year?
02:40pm, Friday, 23'rd Dec 2022 Zacks Investment Research
Here is how Neuronetics (STIM) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Is Neuronetics (STIM) Stock Outpacing Its Medical Peers This Year?
11:17am, Friday, 23'rd Dec 2022
Here is how Neuronetics (STIM) and Cabaletta Bio, Inc. (CABA) have performed compared to their sector so far this year.
Neuronetics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
09:30pm, Wednesday, 07'th Dec 2022 GlobeNewswire Inc.
MALVERN, Pa., Dec. 07, 2022 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM), a commercial stage medical technology company focused on designing, developing, and marketing products that improve
Neuronetics (STIM) Is Up 12.75% in One Week: What You Should Know
05:00pm, Tuesday, 06'th Dec 2022 Zacks Investment Research
Does Neuronetics (STIM) have what it takes to be a top stock pick for momentum investors? Let's find out.
Neuronetics (STIM) Is Up 12.75% in One Week: What You Should Know
01:33pm, Tuesday, 06'th Dec 2022
Does Neuronetics (STIM) have what it takes to be a top stock pick for momentum investors? Let's find out.
